M
10b5-1 Plan
$ Value
$0
Shares
7,000
Price
$0
Filed
Nov 12
Insider
Name
MCLAUGHLIN KEVIN F
Title
—
CIK
0001214938
Roles
Director
Transaction Details
Transaction Date
2025-11-10
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
10,500
Footnotes
The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2024. | These options, representing the right to purchase a total of 17,500 shares, were originally granted on May 3, 2017, and became exercisable in equal monthly installments over the course of one year, contingent upon continued service to the Company.
Filing Info
MCLAUGHLIN KEVIN F's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-11 | VCEL | M | $18K |
| 2026-02-11 | VCEL | ▼ | $243K |
| 2026-02-11 | VCEL | M | $0 |
| 2025-11-19 | IVVD | ▲ | $125K ★ |
| 2025-11-10 | VCEL | M | $18K |
| 2025-11-10 | VCEL | ▼ | $270K |
| 2025-11-10 | VCEL | M | $0 |
| 2025-08-06 | VCEL | M | $19K |
| 2025-08-06 | VCEL | ▼ | $251K |
| 2025-08-06 | VCEL | M | $0 |
Other Insiders at VCEL (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| MCLAUGHLIN KEVIN F | — | $243K | 2026-02-11 |
|
Colangelo Dominick
President and CEO
|
— | — | 2026-02-24 |
| Rubino Alan L | — | — | 2026-03-25 |
| Hagen Heidi | — | $486K | 2026-03-23 |
|
Hopper Jonathan Mark
Chief Medical Officer
|
— | $122K | 2026-04-02 |
|
Halpin Michael
Chief Operating Officer
|
— | $364K | 2026-03-02 |
|
Flynn Sean C.
Chief Legal Officer
|
— | $754K | 2026-03-02 |
|
Mara Joseph Anthony Jr
Chief Financial Officer
|
— | — | 2026-02-24 |
|
SIEGAL JONATHAN
Principal Accounting Officer
|
— | — | 2026-02-24 |